Bloomberg / Mumbai September 26, 2008, 0:14 IST American relief programme suspends funding for three generic medicines. AIDS drugs made by Ranbaxy Laboratories won't be purchased under an American programme to supply medicines to developing countries after the US cited the company for violations in two of its plants. The President's Emergency Plan for AIDS Relief suspended funding for three Ranbaxy generic drugs until the Food and Drug Administration (FDA) says deficiencies have been resolved in one of the plants in India where they're produced, a spokeswoman for the programme said yesterday. The programme provided $8.9 million for Ranbaxy's AIDS drugs last fiscal year, according to the spokeswoman. The FDA said on September 16 that more than 30 generic drugs made by Ranbaxy, India's largest drugmaker, would be blocked at US borders because of manufacturing failures at the two Indian plants. Ranbaxy declined 27 per cent in Mumbai trading after the FDA's action through today. "Funds cannot be used to support new orders'' for the three Ranbaxy drugs